Director of R & D

has over 20 years research experience in the biomedical sciences including 10 years involved in the development of cancer biomarkers for diagnostic testing. Prior to joining 20/20, Dr. Lebowitz was the Director of Research at Panacea Pharmaceuticals, Inc. where he was instrumental in the formation of an in-house CLIA-approved laboratory and the launch of three immunoassays for the early detection of cancer and one companion diagnostic, a gene expression-based test to predict the efficacy of a molecular-targeted therapy. He has experience working with diagnostic regulatory submissions and the FDA. Dr. Lebowitz was trained at Johns Hopkins University, School of Medicine where he did graduate work in biochemistry, cellular and molecular biology and postdoctoral work in immunopathology.